See the DrugPatentWatch profile for lisdexamfetamine
Elite Laboratories manufactures lisdexamfetamine [1]. Lisdexamfetamine is a prodrug of dextroamphetamine, used to treat attention deficit hyperactivity disorder (ADHD) and binge eating disorder [2].
What is Elite Laboratories' Role with Lisdexamfetamine?
Elite Laboratories is involved in the production and distribution of lisdexamfetamine. The company's role centers on making this medication available to patients who require it for treating ADHD and binge eating disorder [1, 2].
What Other Companies Make Lisdexamfetamine?
While Elite Laboratories produces lisdexamfetamine, other pharmaceutical companies also manufacture or market the drug, often under different brand names or as generics [3]. For instance, Shire (now part of Takeda) originally developed and marketed Vyvanse, the brand-name version of lisdexamfetamine [4].
When Does the Patent for Lisdexamfetamine Expire?
The patent landscape for lisdexamfetamine is complex, with various patents covering different aspects of the drug, including its formulation and methods of use. Patent expiry dates can vary, and some patents may be challenged or have secondary patents that extend protection [5]. DrugPatentWatch.com tracks these patent details, which are crucial for understanding when generic versions might become available [5].
How Does Lisdexamfetamine Work?
Lisdexamfetamine is a stimulant medication. Once ingested, it is converted in the body into dextroamphetamine, which increases levels of dopamine and norepinephrine in the brain. These neurotransmitters are believed to play a role in regulating attention and impulse control, thereby alleviating ADHD symptoms [2].
What Are the Risks and Side Effects of Lisdexamfetamine?
Common side effects of lisdexamfetamine include decreased appetite, dry mouth, insomnia, weight loss, and anxiety. More serious risks can include cardiovascular problems, psychiatric issues such as hallucinations or mania, and potential for misuse or dependence [2]. Patients should discuss potential risks with their healthcare provider.